A new cancer treatment involving flash technology is being developed in Europe with the prospect of increased effectiveness and fewer side effects for cancer patients.
The FLASH radiotherapy device is based on technology from the European Laboratory for Particle Physics (CERN); it reduces the period of radiation to a few milliseconds. The device is expected to be ready in two years; clinical trials are planned for 2025. In 2020, a pilot project at the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland, utilized a prototype called FLASHKNiFE, which had been created by THERYQ (ALCEN Group). The new device will be stored in a special new bunker at CHUV.
“A clinical FLASH facility has been developed, with which large, deep-seated tumors are treated using high-energy electrons. The facility is based on